Jun 08, 2023 / 12:30PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
All right. We'll go ahead and get started. Good morning, everybody. Thanks for being here. Welcome to the Jefferies 2023 Global Healthcare Conference. I'm Brandon Couillard, I cover the life science tools and diagnostics sector here at the firm. Very happy to have Mettler-Toledo with us at the conference again this year. And joining us for this conversation, CFO, Shawn Vadala. So Shawn, thanks for being here.
Shawn P. Vadala - Mettler-Toledo International Inc. - CFO
Yes. Thanks for having us, Brandon. Great to see everybody. And look forward to this morning.
Questions and Answers:
Brandon Couillard - Jefferies LLC, Research Division - Equity AnalystMaybe just to kick off, I mean, coming off of a -- I don't want to say it's a controversial sort of Mettler-type quarter. But it was a lot of moving parts right now and a lot of uncertainty as far as kind of what's going on in the biopharma market, what's going on geopolitically. What are some of